Search
Search Results
-
Dynamic change in the peritoneal cancer index based on CT after chemotherapy in the overall survival prediction of gastric cancer patients with peritoneal metastasis
PurposeThe purpose of this research was to investigate the efficacy of the CT-based peritoneal cancer index (PCI) to predict the overall survival of...
-
Improving diagnostic accuracy of identifying gastric cancer patients with peritoneal metastases: tumor-guided cell-free DNA analysis of peritoneal fluid
Detection of peritoneal dissemination (PD) in gastric cancer (GC) patients remains challenging. The feasibility of tumor-guided cell-free DNA (cfDNA)...
-
Peritoneal Tumour DNA in Peritoneal Fluid: Emerging Tool for Peritoneal Metastasis Detection
The prognostic significance of positive peritoneal cytology still varied between cancer types and geographical origin. However, because of the lack...
-
Peritoneal high-fat environment promotes peritoneal metastasis of gastric cancer cells through activation of NSUN2-mediated ORAI2 m5C modification
Peritoneal metastasis (PM) is an important metastatic modality of gastric cancer (GC).It is associated with poor prognosis. The underlying molecular...
-
Predicting Peritoneal Carcinomatosis in Locally Advanced Gastric Cancer: The Significance of Tumor Markers in the Peritoneal Washing
PurposeGastric cancer is the fifth most common malignant tumor worldwide. Many attempts have been made over the years to investigate the relationship...
-
Coexistence of ovarian cancer and peritoneal tuberculosis: a case report
Peritoneal tuberculosis (TB) is known to mimic advanced ovarian cancer. In this case report, we describe a unique case of ovarian cancer...
-
AMIGO2 is involved in the spread of peritoneal metastasis in serous ovarian cancer via promoting adhesion to the peritoneal mesothelial cells
BackgroundAmphoterin-induced gene and open reading frame 2 (AMIGO2) have been reported to be related to the prognosis of colorectal, gastric, and...
-
Establishment and verification of prediction model of occult peritoneal metastasis in advanced gastric cancer
BackgroundTo investigate the risk factors associated with the development of occult peritoneal metastasis in advanced gastric cancer, and establish...
-
Regional Therapy Approaches for Gastric Cancer with Limited Peritoneal Disease
PurposeDespite advances in systemic therapy, outcomes of patients with gastric cancer (GC) peritoneal carcinomatosis (PC) remain poor, in part...
-
Efficacy of palliative surgery for gastric cancer patients with peritoneal metastasis who still have residual peritoneal dissemination after chemotherapy
PurposeGastric cancer patients with peritoneal metastasis (PM) are generally treated with systemic chemotherapy. When PM has disappeared because of...
-
Does total omentectomy prevent peritoneal seeding for advanced gastric cancer with serosal invasion?
BackgroundRadical gastrectomy is composed of gastrectomy, lymph node dissection, and omentectomy. Total omentectomy (TO) is expected to reduce the...
-
2022 Peritoneal Surface Oncology Group International Consensus on HIPEC Regimens for Peritoneal Malignancies: Colorectal Cancer
BackgroundSelected patients with peritoneal metastases of colorectal cancer (PM-CRC) can benefit from potentially curative cytoreductive surgery...
-
Dual-energy CT quantitative parameters to evaluate occult peritoneal metastasis in advanced gastric cancer preoperatively
PurposeTo explore whether dual-energy CT (DECT) quantitative parameters could provide analytic value for the diagnosis of patients with occult...
-
Suppression of galectin-4 attenuates peritoneal metastasis of poorly differentiated gastric cancer cells
BackgroundPeritoneal dissemination, most often seen in metastatic and/or recurrent gastric cancer, is an inoperable condition that lacks effective...
-
Bidirectional Chemotherapy in Advanced Colorectal Cancer Peritoneal Metastases
Colorectal cancer (CRC) patients with extensive peritoneal metastases who are not candidates for CRS-HIPEC have poor prognoses. We evaluated the role...
-
Prognostic significance of the immuno-peritoneal cancer index in peritoneal metastatic patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
PurposeA valid comparison of immune function among different patients with different primary pathologies or even with different tumour burdens...
-
Important Predictive Factors for the Prognosis of Patients With Peritoneal Metastasis of Gastric Cancer
BackgroundThis study investigated predictive factors for patients with peritoneal metastases of gastric cancer (PMGC) who underwent conversion...
-
Conversion therapy with pembrolizumab for a peritoneal metastasis of rectal cancer causing hydronephrosis in a patient with Lynch syndrome
A 44-year-old woman with Lynch syndrome was referred to our hospital for treatment of recurrence of microsatellite instability-high rectal cancer. [ 18 ...
-
Prognostic value of hyperthermic intraperitoneal chemotherapy in gastric cancer with synchronous peritoneal metastases: a real-world retrospective study
PurposePeritoneal metastasis in gastric cancer (GC) is a late-stage condition with a poor prognosis. Cytoreductive surgery combined with hyperthermic...
-
Evaluation of peritoneal Carcinoembryonic Antigen as a survival prognostic factor in gastric cancer patients: a single western center experience
The aim of this study is to define the importance of peritoneal CEA (pCEA) as a prognostic factor of overall survival (OS) and disease-free survival...
